Back
Apellis Pharmaceuticals Vs. Argan Industry Stock Comparison
Sell
19
APLS
Apellis Pharmaceuticals
Last Price:
35.63
Seasonality Move:
15.53%
Buy
74
AGX
Argan
Last Price:
88.48
Seasonality Move:
-1.01%
Sell
19
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $35.53. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
74
Argan (AGX)
is a Buy
Is Argan a Buy, Sell or Hold?
- The current Argan [AGX] share price is $89.19. The Score for AGX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
- AGX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $35.53
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
AGX Stock Price Chart
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 39.84 | Sell |
Chaikin Money Flow: | -728829 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.93 - 39.81) | Sell |
Bollinger Bands (100): | (36.69 - 43.03) | Sell |
AGX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.48 | Buy |
Relative Strength Index (14 RSI): | 63.3 | Buy |
Chaikin Money Flow: | -159234 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (71.38 - 87.04) | Buy |
Bollinger Bands (100): | (66.34 - 80.1) | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.1 | Sell |
20-day SMA: | 38.7 | Sell |
50-day SMA: | 38.06 | Sell |
200-day SMA: | 50.38 | Sell |
8-day EMA: | 37.4 | Sell |
20-day EMA: | 38.04 | Sell |
50-day EMA: | 38.67 | Sell |
200-day EMA: | 46.02 | Sell |
AGX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 90.17 | Sell |
20-day SMA: | 80.91 | Buy |
50-day SMA: | 76.7 | Buy |
200-day SMA: | 60.72 | Buy |
8-day EMA: | 87.85 | Buy |
20-day EMA: | 82.87 | Buy |
50-day EMA: | 77.77 | Buy |
200-day EMA: | 64.32 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.71 per share, an increase next quarter of $0.24 per share, an increase this year of $3.17 per share, and an increase next year of $1.50 per share.
Argan Earnings Growth & AGX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.40 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.20 per share, and an increase next year of $1.94 per share.
Apellis Pharmaceuticals Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Argan Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |